Company Announces Residency at Johnson & Johnson Innovation’s JLABS @ TMC in the Texas Medical Center.
$6.1 Million Lead Investment From UK-based The Wellcome Trust is Being Used to Develop Less-Invasive, Non-Blood-Contacting Soft Robotic Heart Device to Treat Heart Failure (HF).
